We are live on ! Find out more
XBIT icon

XBiotech
XBIT

45 hedge funds and large institutions have $11.1M invested in XBiotech in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.99% less ownership

Funds ownership: 11.04% → 10.05% (-0.99%)

20% less funds holding

Funds holding: 56 → 45 (-11)

29% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 17

41% less capital invested

Capital invested by funds: $18.9M → $11.1M (-$7.84M)

69% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 16

Holders
45
Holders Change
-11
Holders Change %
-19.64%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
17
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$482K
2
Renaissance Technologies
Renaissance Technologies
New York
+$362K
3
CS
Credit Suisse
Switzerland
+$177K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$177K
5
RC
RBF Capital
California
+$109K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$691K
2
Citadel Advisors
Citadel Advisors
Florida
-$455K
3
Morgan Stanley
Morgan Stanley
New York
-$417K
4
E
Ergoteles
New York
-$395K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$380K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.09M -$828 -176 -0%
CS
2
Credit Suisse
Switzerland
$955K +$177K +37,561 +17%
BlackRock
3
BlackRock
New York
$938K +$18.8K +4,002 +2%
Renaissance Technologies
4
Renaissance Technologies
New York
$563K +$362K +76,800 +98%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$549K +$1.62K +345 +0.2%
Millennium Management
6
Millennium Management
New York
$500K -$691K -146,692 -52%
OMC
7
Oasis Management Company
Cayman Islands
$497K – – –
BCM
8
Bridgeway Capital Management
Texas
$481K +$482K +102,500 +336%
Morgan Stanley
9
Morgan Stanley
New York
$409K -$417K -88,640 -44%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$312K -$380K -80,822 -48%
Two Sigma Investments
11
Two Sigma Investments
New York
$279K +$66.1K +14,048 +22%
Two Sigma Advisers
12
Two Sigma Advisers
New York
$251K +$177K +37,500 +118%
Connor, Clark & Lunn Investment Management (CC&L)
13
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$246K +$88.8K +18,863 +38%
State Street
14
State Street
Massachusetts
$207K -$1.99K -423 -0.7%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$201K – – –
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$175K +$60.3K +12,819 +36%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$163K -$19.1K -4,047 -8%
Northern Trust
18
Northern Trust
Illinois
$162K +$3.55K +754 +2%
HF
19
HRT Financial
New York
$148K -$90.4K -19,215 -32%
State of Wisconsin Investment Board
20
State of Wisconsin Investment Board
Wisconsin
$108K -$61.5K -13,066 -31%
RC
21
RBF Capital
California
$84K +$109K +23,172 New
TI
22
Trexquant Investment
Connecticut
$80K -$42.3K -8,994 -29%
SFI
23
Susquehanna Fundamental Investments
Pennsylvania
$77K +$101K +21,400 New
Fidelity Investments
24
Fidelity Investments
Massachusetts
$73K -$4.79K -1,017 -5%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$64K – – –
1
2 3

XBIT Hedge Fund Activity: Q3 2022 in Review

45 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q3 2022, worth a combined $11.1M — down 41% from $18.9M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of XBIT and 5 opened new positions — a net loss of 11 holders — while 17 trimmed existing stakes and 12 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $482K. The largest seller was Millennium Management, cutting an estimated $691K.

  • 45 institutional investors held XBiotech (XBIT) as of Q3 2022, down from 56 in Q2 2022.
  • Funds reported $11.1M of XBiotech stock for Q3 2022, down 41% quarter-over-quarter.
  • 5 funds opened new XBiotech positions in Q3 2022 and 16 closed out, a net change of -11 holders.
  • The largest XBiotech buyer in Q3 2022 was Bridgeway Capital Management, an estimated $482K added.
  • The largest XBiotech seller in Q3 2022 was Millennium Management, an estimated $691K sold.

Based on aggregated 13F filings for Q3 2022.